Sort
39,280 grants matching “leukemia”
Clinical Research Support
$318,812Richard M Stone · Dana-Farber Cancer Inst · P01 · FY2021 · CA
Genomic Expert Curation Panels for Pediatric Malignancies
$318,793Obi L. Griffith · Washington University · U24 · FY2022 · CA
Restoring T Cell Responses to Therapeutic Tumor Vaccines
$318,780Ephraim J Fuchs · Johns Hopkins University · R01 · FY2009 · CA
Restoring T Cell Responses to Therapeutic Tumor Vaccines
$318,780Ephraim J Fuchs · Johns Hopkins University · R01 · FY2008 · CA
Drug Resistance in Multiple Myeloma
$318,737William S. Dalton · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2006 · CA
Project 2: Preclinical Drug Approaches to Chronic Graft-vs.-Host-Disease Prevention and Treatment
$318,733Bruce R. Blazar · Dana-Farber Cancer Inst · P01 · FY2019 · CA
Retroviral Regulatory Sequences with Coding Sequences
$318,732Karen L. Beemon · Johns Hopkins University · R01 · FY2014 · CA
Mechanisms mediating immune response upon sensing of nuclear viral DNA
$318,731Ileana M. Cristea · Princeton University · R01 · FY2015 · GM
ENGINEERING ORTHOGONAL PROTEIN KINASE AND NUCLEOTIDES
$318,680University Of California San Francisco · R01 · FY2002 · CA
Transdisciplinary Collaboration and Coordination
$318,644Richard James Gilbertson · St. Jude Children'S Research Hospital · P30 · FY2016 · CA
Development of Novel Agents Active against Hepatitis B Virus
$318,638Hiroaki Mitsuya · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Epigenetic Regulation of Germ Cell Differentiation from a Stem Cell Lineage
$318,618Xin Chen · Johns Hopkins University · R01 · FY2013 · HD
PEDIATRIC ONCOLOGY GROUP
$318,607Stanford University · U10 · FY2002 · CA
An Integrated Biochemical and Structural Approach to Delineating the Biology of EWSR1
$318,570David Steven Libich · University Of Texas Hlth Science Center · R01 · FY2022 · GM
Notch Target Gene Regulation in Normal and Malignant T Cells
$318,538Warren S Pear · Brigham And Women'S Hospital · P01 · FY2014 · CA
PROLIFERATIVE EFFECTS OF HTLV1
$318,527Washington University · R01 · FY2001 · CA
Role of Asxl1 in normal hematopoiesis and pathogenesis of myeloid malignancies
$318,513Feng-Chun Yang · University Of Miami School Of Medicine · R01 · FY2015 · CA
Role of Asxl1 in normal hematopoiesis and pathogenesis of myeloid malignancies
$318,513Feng-Chun Yang · University Of Miami School Of Medicine · R01 · FY2017 · CA
Therapeutic Targeting of Leukemia-Microenvironmental Interactions
$318,513Laura Maria Calvi · University Of Rochester · R01 · FY2016 · CA
Therapeutic Targeting of Leukemia-Microenvironmental Interactions
$318,513Laura Maria Calvi · University Of Rochester · R01 · FY2017 · CA
Function of the PR domain of the MDSI-EVI1 in MLL fusion protein leukemogenesis
$318,513Archibald S Perkins · University Of Rochester · R01 · FY2015 · CA
Function of the PR domain of the MDSI-EVI1 in MLL fusion protein leukemogenesis
$318,513Archibald S Perkins · University Of Rochester · R01 · FY2014 · CA
Therapeutic Targeting of Leukemia-Microenvironmental Interactions
$318,513Laura Maria Calvi · University Of Rochester · R01 · FY2015 · CA
Function of the PR domain of the MDSI-EVI1 in MLL fusion protein leukemogenesis
$318,513Archibald S Perkins · University Of Rochester · R01 · FY2017 · CA
Function of the PR domain of the MDSI-EVI1 in MLL fusion protein leukemogenesis
$318,513Archibald S Perkins · University Of Rochester · R01 · FY2018 · CA